Racura Oncology Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 25, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	432	204	311	200	311	527
Market Cap Growth	104.00%	-34.32%	55.59%	-35.78%	-41.00%	546.75%
Enterprise Value	419	185	297	173	274	522
Last Close Price	2.38	1.18	1.82	1.23	1.95	3.67
PS Ratio	71.55	33.78	64.27	63.73	439.48	1360.92
PB Ratio	27.00	12.75	16.97	7.84	8.62	38.42
P/TBV Ratio	32.07	15.14	20.05	8.92	9.50	52.37
EV/Sales Ratio	69.29	30.68	61.43	55.32	387.06	1346.52
Net Debt / Equity Ratio	-0.85	-0.85	-0.94	-0.84	-0.93	-0.68
Net Debt / EBITDA Ratio	3.08	3.08	1.29	2.11	3.07	1.53
Asset Turnover	0.32	0.32	0.21	0.10	0.03	0.04
Quick Ratio	9.42	9.42	9.26	20.16	23.71	18.07
Current Ratio	10.29	10.29	9.32	20.44	24.10	20.24
Return on Equity (ROE)	-27.89%	-27.89%	-63.10%	-32.22%	-44.96%	-65.32%
Return on Assets (ROA)	-15.63%	-15.63%	-36.41%	-20.41%	-27.05%	-39.39%
Return on Capital Employed (ROCE)	-29.40%	-29.40%	-74.40%	-41.10%	-31.00%	-46.30%
Earnings Yield	-1.11%	-2.34%	-4.45%	-4.97%	-3.60%	-1.20%
Buyback Yield / Dilution	-4.81%	-4.81%	-2.35%	-4.83%	-17.06%	-22.86%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.